Targeted microwave sensitizers reprogram cancer-associated fibroblasts via nitric oxide delivery to potentiate hepatocellular carcinoma therapy
Engineered nanoparticles enhance liver cancer surgery by activating the immune system to attack remaining disease, addressing a major treatment limitation.
This preclinical study developed a multifunctional nanoparticle that enhances microwave ablation of liver cancer by reprogramming cancer-associated fibroblasts and activating anti-tumor immunity. The approach addresses the major limitation of incomplete tumor elimination and post-ablation immunosuppression.
What the study was
- Study design
- Preclinical (in vivo murine model)
- Population
- HCC tumor-bearing mice
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Journal of Controlled Release
Why it surfaced
Novel nanoplatform for HCC microwave ablation but preclinical animal model only. HCC not a primary watchlist focus.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.